Stem Cells

P183 - The effect of blood-derived products on the regenerative potential of adipose-derived stem cells originated from different fat locations

Corresponding Author
No Significant Commercial Relationship
Presentation Topic
Stem Cells
Poster Rating




Novel cell sources are currently explored for regenerative joint procedures.

Adipose tissue-derived stem cells (ASCs) have recently been under investigation as a potential cell source.

The aim of this study was to investigate a potentially superior chondrogenic and osteogenic differentiation of ASCs by supplementation with different blood derivatives in in vitro.

Methods and Materials

Fat tissue was harvested from 3 donors, 3 locations each (Hoffa, subcutaneous fat and suprapatellar pouch) during TKA.

ASCs were isolated and cultured in standard growth media.

The expression of specific mesenchymal stem cell markerswasanalysedby flow cytometry (positive: CD90, CD73, CD105).

Platelet-rich plasma (PRP) was prepared either with EDTA (ePRP) or citrate (cPRP) as anticoagulants. HypACT was produced according to the manufacturer´s protocol.

Cells were supplemented with 10% of each blood product in induction medias.

Metabolic activity was assessed by XTT assays.

Differentiation was assessed by staining (osteogenic: alizarin red and dye extraction curve, chondrogenic: Safranin O) and qPCR (osteogenic: ALPL, COL1, RUNX; chondrogenic: SOX9, COL2).


FACS: Cells of all locations expressed MSC markers after isolation (CD90, CD73, CD105).

Metabolic activity: A significant difference was observed in cells supplemented with either cPRP or hypACT in Hoffa cells (fold change day 6: 12 (cPRP) 10 (hypACT) versus 3 (FCS) (p<0,05)).

Osteogenic Differentiation: Alizarin Red Staining and dye extraction curves showed highest mineralization under hypACT and cPRP supplementation both in Hoffa and pouch stem cells (p<0,05).

qPCR did not show significant differences amongst the groups.

Chondrogenic differentiation: qPCR showed highest fold changes amongst Hoffa cells supplemented with ePRP (fold change to day 0: SOX9:38; COL2 1,4).


Preliminary data implypotential beneficial effectsof blood-products on the differentiation potential of ASCs.

Non-anticoagulated serum supplementation may be favourable.

Best differentiation wasobserved withHoffa stem cells.